Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the clinical and genetic spectrum, BMC Medical Genetics

Por um escritor misterioso

Descrição

Background Rubinstein-Taybi syndrome (RSTS) is a rare autosomal dominant neurodevelopmental disorder characterized by broad thumbs and halluces. RSTS is caused by mutations in CREBBP and in EP300 genes in 50–60% and 8%, respectively. Up to now, 76 RSTS-EP300 patients have been described. We present the clinical and molecular characterization of a cohort of RSTS patients carrying EP300 mutations. Methods Patients were selected from a cohort of 72 individuals suspected of RSTS after being negative in CREBBP study. MLPA and panel-based NGS EP300 were performed. Results Eight patients were found to carry EP300 mutations. Phenotypic characteristics included: intellectual disability (generally mild), postnatal growth retardation, infant feeding problems, psychomotor and language delay and typical facial dysmorphisms (microcephaly, downslanting palpebral fissures, columella below the alae nasi, and prominent nose). Broad thumbs and/or halluces were common, but angulated thumbs were only found in two patients. We identified across the gene novel mutations, including large deletion, frameshift mutations, nonsense, missense and splicing alterations, confirming de novo origin in all but one (the mother, possibly underdiagnosed, has short and broad thumbs and had learning difficulties). Conclusions The clinical evaluation of our patients corroborates that clinical features in EP300 are less marked than in CREBBP patients although it is difficult to establish a genotype-phenotype correlation although. It is remarkable that these findings are observed in a RSTS-diagnosed cohort; some patients harbouring EP300 mutations could present a different phenotype. Broadening the knowledge about EP300-RSTS phenotype may contribute to improve the management of patients and the counselling to the families.
Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the  clinical and genetic spectrum, BMC Medical Genetics
Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the clinical and genetic spectrum, BMC Medical Genetics
Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the  clinical and genetic spectrum, BMC Medical Genetics
A case with Rubinstein-Taybi syndrome: A novel frameshift mutation in the CREBBP gene.
Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the  clinical and genetic spectrum, BMC Medical Genetics
Sanger sequencing confirmation. A de novo in-frame deletion variant
Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the  clinical and genetic spectrum, BMC Medical Genetics
Genes, Free Full-Text
Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the  clinical and genetic spectrum, BMC Medical Genetics
Case report: a Chinese girl like atypical Rubinstein–Taybi syndrome caused by a novel heterozygous mutation of the EP300 gene, BMC Medical Genomics
Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the  clinical and genetic spectrum, BMC Medical Genetics
Comparison of typical features in EP300-patients found in literature
Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the  clinical and genetic spectrum, BMC Medical Genetics
The behavioral phenotype of Rubinstein–Taybi syndrome: A scoping review of the literature - Awan - 2022 - American Journal of Medical Genetics Part A - Wiley Online Library
Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the  clinical and genetic spectrum, BMC Medical Genetics
PDF) Genetic heterogeneity in Rubinstein-Taybi syndrome: Delineation of the phenotype of the first patients carrying mutations in EP300
Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the  clinical and genetic spectrum, BMC Medical Genetics
Frontiers Impaired Regulation of Histone Methylation and Acetylation Underlies Specific Neurodevelopmental Disorders
Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the  clinical and genetic spectrum, BMC Medical Genetics
Confirmation of EP300 gene mutations as a rare cause of Rubinstein–Taybi syndrome
de por adulto (o preço varia de acordo com o tamanho do grupo)